個案資料
了解個案內容與學習目標，選擇授課教師及使用課程。
Building an Integrated Biopharma Company: Crucell (B)
內容大綱
The Crucell (B) case updates events at Crucell since 2009. In September, 2009, Johnson & Johnson acquired 18% of Crucell for $400 million. This investment was part of a business development deal. Subsequently, in 2012, Johnson & Johnson acquired Crucell for $2.8 billion.